Scientific Advisory Board
Patent Portfolio
Patent Counsel
CAD Resources



Company OverviewCoronary Artery DiseaseTechnical ResourcesEmployment OpportunitiesWhat's New

Patent Portfolio

The portfolio includes broad disclosures supporting surgical, percutaneous and less invasive methods for delivery of both balloon deployed and self-expanding stents to connect the left ventricle and the coronary circulation. Percardia's VSTENT™ Myocardial Implant system embodies the seminal patents exclusively licensed from Wilk Patent Development Corp., in the emerging field of ventricular revascularization. Sixty-seven (67) issued and licensed US patents as well as numerous pending applications provide the foundation for the Company's product development activities. These patents are believed to constitute seminal filings in the field (with several based upon filing dates as early as October 1992), and provide substantial patent coverage for the use of implantable devices such as VSTENT™ Myocardial Implant and numerous methods of delivery.


Advisory Board | Patent Portfolio | Patent Counsel | CAD Resources

Company | Coronary Artery Disease | Resources | Employment | What's New

Percardia Inc.
Heron Cove Office Park
10 Al Paul Lane, Suite 202
Merrimack, NH 03054
© 2001 Percardia Inc.